Bradlee Heckmann

    PhD, Neuroscientist, Chief Scientific Officer
    USF Health Neuroscience Institute & Byrd Alzheimer's Center, Asha Therapeutics

    Dr. Heckmann is a principal investigator at the USF Health Neuroscience Institute and Byrd Alzheimer’s Center with academic faculty appointments at the University of South Florida Morsani College of Medicine and the University of South Florida College of Engineering

    In addition to his academic appointments, Dr. Heckmann is the co-founder and Chief Scientific Officer of Asha Therapeutics. Dr. Heckmann’s major scientific discoveries and advancements include the discovery and characterization of LC3-associated endocytosis (LANDO) in immune regulation in neurodegenerative diseases, neuroinflammation, and neuro-oncology research published in journals including Cell and Science Advances.

    Dr. Heckmann has received multiple awards and honors including a Ruth L. Kirschstein National Research Service Award, a National Cancer Institute Award in Pediatric Oncology, an Excellence in Science Award from the AAAS, and is an International Fellow of the Royal Society of Medicine.